Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis

Impact of Comorbidities on Hospitalization Costs Following Hip Fracture

(2012) Lucas E Nikkel et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

(2011) S. Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Secular trends in the incidence of hip and other osteoporotic fractures

(2011) C. Cooper et al.   OSTEOPOROSIS INTERNATIONAL

Age, cohort and period effects on hip fracture incidence: analysis and predictions from New Zealand data 1974-2007

(2010) J. Langley et al.   OSTEOPOROSIS INTERNATIONAL

Change in hip fracture incidence over the last 6 years in France

(2010) M. Maravic et al.   OSTEOPOROSIS INTERNATIONAL

Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis

(2010) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

Age-specific incidence of hip fracture in the elderly: A healthy decline

(2010) C. Green et al.   SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

Incidence and Mortality of Hip Fractures in the United States

(2009) Carmen A. Brauer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in Hip Fracture Rates in Canada

(2009) William D. Leslie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of hip fracture in the Republic of Ireland and future projections: a population-based study

(2009) M. K. Dodds et al.   OSTEOPOROSIS INTERNATIONAL

Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006

(2009) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends

(2009) Hajime Orimo et al.   Archives of Osteoporosis

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

(2008) Jean-Yves Reginster et al.   ARTHRITIS AND RHEUMATISM

Secular trends in hip fracture incidence and recurrence

(2008) L. J. Melton et al.   OSTEOPOROSIS INTERNATIONAL

Reversal of the hip fracture secular trend is related to a decrease in the incidence in institution-dwelling elderly women

(2008) E. Guilley et al.   OSTEOPOROSIS INTERNATIONAL

Hip fracture incidence in the elderly in Austria: An epidemiological study covering the years 1994 to 2006

(2008) Eva Mann et al.   BMC Geriatrics

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

(2007) Pierre D. Delmas et al.   BONE